Optimizing Pembrolizumab Therapy With Timing and Intensification With Axitinib
Status:
Not yet recruiting
Trial end date:
2027-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this research is to test the response of study participants' tumor to
pembrolizumab alone, and in combination with axitinib, and to see what effects (good and bad)
these drugs have on patients with advanced kidney cancer.